TPMT and NUDT15 polymorphisms in thiopurine induced leucopenia in inflammatory bowel disease: a prospective study from India (original) (raw)
Influences of Thiopurine Methyltransferase Genotype and Activity on Thiopurine-induced Leukopenia in Korean Patients With Inflammatory Bowel Disease
Suk-kyun Yang
Journal of Clinical Gastroenterology, 2010
View PDFchevron_right
Thiopurine-methyltransferase variants in inflammatory bowel disease: prevalence and toxicity in Brazilian patients
Renata Fróes
World journal of gastroenterology : WJG, 2014
View PDFchevron_right
Thiopurine S-methyltransferase genetic polymorphisms in adult patients with inflammatory bowel diseases in the Latvian population
Aldis Pukitis
Therapeutic Advances in Gastroenterology
View PDFchevron_right
Prevalence of thiopurine S-methyltransferase gene polymorphisms in patients with inflammatory bowel disease from the island of Crete, Greece
Elias Kouroumalis
European Journal of Gastroenterology & Hepatology, 2017
View PDFchevron_right
Thiopurine S -methyltransferase genotype and the use of thiopurines in paediatric inflammatory bowel disease Greek patients
D. Vlachodimitropoulos, Ioanna Panayotou
Journal of Clinical Pharmacy and Therapeutics, 2010
View PDFchevron_right
Association between Thiopurine S-methyltransferase Polymorphisms and Thiopurine-Induced Adverse Drug Reactions in Patients with Inflammatory Bowel Disease: A Meta-Analysis
Son Duong
PloS one, 2015
View PDFchevron_right
Thiopurine S-Methyltransferase Gene Polymorphisms in a Healthy Slovak Population and Pediatric Patients with Inflammatory Bowel Disease
Alica Chocholova
Nucleosides, Nucleotides and Nucleic Acids, 2013
View PDFchevron_right
Predictive role of NUDT15 variants on thiopurine-induced myelotoxicity in Asian inflammatory bowel disease patients
Madeline Tjai
Pharmacogenomics, 2018
View PDFchevron_right
Nudix Hydroxylase 15 Mutations Strongly Predict Thiopurine-Induced Leukopenia Across Different Asian Ethnicities: Implications for Screening in a Diverse Population
kee seang Chew
Frontiers in Medicine
View PDFchevron_right
Thiopurine metabolites variations during co-treatment with aminosalicylates for inflammatory bowel disease: Effect of N-acetyl transferase polymorphisms
Paolo Lionetti
World journal of gastroenterology : WJG, 2015
View PDFchevron_right
Thiopurine S-methyltransferase (TPMT) genotype does not predict adverse drug reactions to thiopurine drugs in patients with inflammatory bowel disease
Rebecca Roberts, Richard Gearry, Murray Barclay
Alimentary Pharmacology and Therapeutics, 2003
View PDFchevron_right
Pharmacogenetics during standardised initiation of thiopurine treatment in inflammatory bowel disease
Sven Almer
Gut, 2006
View PDFchevron_right
The impact of thiopurine-S-methyltransferase genotype on the adverse drug reactions to azathioprine in patients with inflammatory bowel diseases
L. Kadasi, T. Koller
Bratislavské lekárske listy, 2013
View PDFchevron_right
Association of Genetic Variants in NUDT15 With Thiopurine-Induced Myelosuppression in Patients With Inflammatory Bowel Disease
David Rampton
JAMA, 2019
View PDFchevron_right
Biomarker-based thiopurine therapy for inflammatory bowel disease
Momir Mikov
Macedonian Pharmaceutical Bulletin
View PDFchevron_right
Allelic variants of the thiopurine s-methyltranferase deficiency in patients with ulcerative colitis and in healthy controls
Cesar Diaz
The American Journal of Gastroenterology, 2000
View PDFchevron_right
Thiopurine metabolite level and toxicity in Indians with inflammatory bowel disease
Tester Ashavaid
JGH Open, 2017
View PDFchevron_right
Nonsynonymous Polymorphism in Guanine Monophosphate Synthetase Is a Risk Factor for Unfavorable Thiopurine Metabolite Ratios in Patients With Inflammatory Bowel Disease
Andre Van Rij
Inflammatory bowel diseases, 2018
View PDFchevron_right
A Practical Non-Extraction Direct Liquid Chromatography Method for Determination of Thiopurine S-Methyltransferase Activity in Inflammatory Bowel Disease
Amir Kiani
Acta medica Iranica, 2017
View PDFchevron_right
Thiopurines in inflammatory bowel disease: New strategies for optimization of pharmacotherapy?
Anthony Lopez
Current Gastroenterology Reports, 2006
View PDFchevron_right
Thiopurines in inflammatory bowel disease: pharmacogenetics, therapeutic drug monitoring and clinical recommendations
Johanna Escher
Digestive and Liver Disease, 2005
View PDFchevron_right
Pharmacogenetics of thiopurine therapy in paediatric IBD patients
Johanna Escher
Alimentary Pharmacology and Therapeutics, 2006
View PDFchevron_right
Thiopurine methyltransferase genotype distribution in patients with Crohn's disease
Jens Frederik Dahlerup
Alimentary Pharmacology and Therapeutics, 2003
View PDFchevron_right
Therapeutic Monitoring of Thiopurine Metabolites: Validation of an HPLC Method and Preliminary Findings from a Small Cohort of Malaysian Patients with Inflammatory Bowel Disease
Prof. Dr. Suzana Makpol
Sains Malaysiana, 2022
View PDFchevron_right
On Therapeutic Drug Monitoring of Thiopurines in Inflammatory Bowel Disease; Pharmacology, Pharmacogenomics, Drug Intolerance and Clinical Relevance
Ad van Bodegraven
Current Drug Metabolism, 2009
View PDFchevron_right
Thiopurine metabolite measurement leads to changes in management of inflammatory bowel disease
Matt Doogue
Internal Medicine Journal, 2013
View PDFchevron_right
Incidence, risk factors and clinical course of thiopurine-induced liver injury in patients with inflammatory bowel disease
jose ponce
Alimentary Pharmacology and Therapeutics, 2005
View PDFchevron_right